240 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
607 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
3,500 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
3,500 followers
Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review. https://t.co/QiY7lwzgfx
2,606 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
194 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
5,169 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
1,423 followers
RT @RheumNow: What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secuk…
21,691 followers
What works in Dactylitis? Literature review suggests ustekinumab, ixekizumab, adalimumab, and apremilast are efficient. Secukinumab, clazakizumab, abatacept, and tofacitinib were promising. Brodalumab was ineffective https://t.co/SLPcjBaNAv